CL2008001295A1 - Metodo para la produccion de un virus que comprende proporcionar una celula huesped que ha sido infectada por el virus, cultivar la celula a dos diferentes temperaturas y recolectar el virus obtenido. - Google Patents

Metodo para la produccion de un virus que comprende proporcionar una celula huesped que ha sido infectada por el virus, cultivar la celula a dos diferentes temperaturas y recolectar el virus obtenido.

Info

Publication number
CL2008001295A1
CL2008001295A1 CL2008001295A CL2008001295A CL2008001295A1 CL 2008001295 A1 CL2008001295 A1 CL 2008001295A1 CL 2008001295 A CL2008001295 A CL 2008001295A CL 2008001295 A CL2008001295 A CL 2008001295A CL 2008001295 A1 CL2008001295 A1 CL 2008001295A1
Authority
CL
Chile
Prior art keywords
virus
cell
harvesting
infected
production
Prior art date
Application number
CL2008001295A
Other languages
English (en)
Inventor
Manfred Reiter
Leopold Grillberger
Wolfgang Mundt
Original Assignee
Baxter Int
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int, Baxter Healthcare Sa filed Critical Baxter Int
Publication of CL2008001295A1 publication Critical patent/CL2008001295A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Método para la producción de un virus que comprende proporcionar una célula huésped que ha sido infectada por el virus, cultivar la célula a dos diferentes temperaturas y recolectar el virus obtenido.
CL2008001295A 2007-05-04 2008-05-05 Metodo para la produccion de un virus que comprende proporcionar una celula huesped que ha sido infectada por el virus, cultivar la celula a dos diferentes temperaturas y recolectar el virus obtenido. CL2008001295A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92769307P 2007-05-04 2007-05-04

Publications (1)

Publication Number Publication Date
CL2008001295A1 true CL2008001295A1 (es) 2009-06-26

Family

ID=39670405

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001295A CL2008001295A1 (es) 2007-05-04 2008-05-05 Metodo para la produccion de un virus que comprende proporcionar una celula huesped que ha sido infectada por el virus, cultivar la celula a dos diferentes temperaturas y recolectar el virus obtenido.

Country Status (19)

Country Link
US (2) US8426124B2 (es)
EP (1) EP2155863B1 (es)
JP (2) JP5352578B2 (es)
KR (1) KR101581228B1 (es)
CN (2) CN101688186A (es)
AR (1) AR066450A1 (es)
AU (1) AU2008248905B2 (es)
BR (1) BRPI0811533A2 (es)
CA (1) CA2687122C (es)
CL (1) CL2008001295A1 (es)
ES (1) ES2521496T3 (es)
HK (2) HK1137780A1 (es)
IL (1) IL201896A (es)
MX (1) MX2009011899A (es)
PE (1) PE20090214A1 (es)
RU (1) RU2476594C2 (es)
TW (1) TWI447226B (es)
WO (1) WO2008135230A1 (es)
ZA (1) ZA200907744B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2914163B1 (fr) * 2007-04-02 2009-06-05 Oreal Applicateur pour appliquer une composition sur les cils
JP2015514420A (ja) 2012-04-18 2015-05-21 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 複製可能な水疱性口内炎ウイルス

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1526172A1 (de) * 1965-04-22 1969-07-31 Steinmueller Gmbh L & C Aus mehreren Stufen aufgebauter Regenerativ-Waermeaustauscher
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen
US4301249A (en) * 1980-07-23 1981-11-17 Merck & Co., Inc. High titer production of hepatitis A virus
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE19612967A1 (de) * 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
RU2181295C1 (ru) * 2000-12-27 2002-04-20 Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН (учреждение) Вирионная цитомегаловирусная вакцина и способ ее получения
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
AU2003226012B2 (en) * 2002-03-29 2007-05-24 Merck Sharp & Dohme Corp. Methods of virus production
EP2494987A1 (en) * 2003-04-25 2012-09-05 MedImmune Vaccines, Inc. Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
JP2007068401A (ja) * 2003-08-07 2007-03-22 Chemo Sero Therapeut Res Inst 西ナイルウイルスワクチン
DK2368975T3 (en) * 2004-12-23 2015-01-05 Medimmune Llc Non-tumorigenic MDCK cell line for the propagation of viruses

Also Published As

Publication number Publication date
JP2010525799A (ja) 2010-07-29
HK1216104A1 (zh) 2016-10-14
KR20100017593A (ko) 2010-02-16
RU2009144970A (ru) 2011-06-10
AU2008248905B2 (en) 2014-05-29
ES2521496T3 (es) 2014-11-12
PE20090214A1 (es) 2009-03-20
HK1137780A1 (en) 2010-08-06
CN101688186A (zh) 2010-03-31
CN104962525A (zh) 2015-10-07
KR101581228B1 (ko) 2015-12-30
CA2687122A1 (en) 2008-11-13
US8426124B2 (en) 2013-04-23
JP2013198502A (ja) 2013-10-03
EP2155863B1 (en) 2014-08-13
JP5352578B2 (ja) 2013-11-27
US20100239606A1 (en) 2010-09-23
TW200914616A (en) 2009-04-01
AR066450A1 (es) 2009-08-19
EP2155863A1 (en) 2010-02-24
WO2008135230A1 (en) 2008-11-13
RU2476594C2 (ru) 2013-02-27
MX2009011899A (es) 2010-03-30
JP5978172B2 (ja) 2016-08-24
AU2008248905A1 (en) 2008-11-13
US20080286307A1 (en) 2008-11-20
IL201896A0 (en) 2011-08-01
IL201896A (en) 2013-08-29
TWI447226B (zh) 2014-08-01
ZA200907744B (en) 2010-08-25
BRPI0811533A2 (pt) 2014-10-14
CA2687122C (en) 2017-06-13

Similar Documents

Publication Publication Date Title
ECSP15011603A (es) Subunidades de vacunas de inmersión para peces
CO6511251A2 (es) Compuestos quimicos
CL2011000136A1 (es) Compuestos derivados de 3-fenilpiridin-2-ona, inhibidores de rna polimerasa dependiente de rna viral; composicion faramceutica que comprende dichos compuestos; y su uso para el tratamiento de una enfermedad causada por el virus de la hepatitis c.
CO6990737A2 (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos
WO2014160129A3 (en) Complement component c5 irna compositions and methods of use thereof
BRPI0919252A2 (pt) Métodos para cultivar células, propagação e purificação de vírus
GT201200249A (es) Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
BRPI0918430A2 (pt) 4-fenil-1h-pirazóis inseticidas.
BRPI0816429A2 (pt) microorganismo, e, método para a produção de um l-aminoácido.
BRPI0813437A2 (pt) Composto, composição, e métodos para inibir uma resposta de etileno em uma planta, e para prolongar a vida de uma planta paisagística.
JP2011175111A5 (es)
CL2012003346A1 (es) Composicion herbicida que comprende flumioxazina, saflufenacil y glifosato; método de control del crecimiento de maleza.
BR112014026149A2 (pt) método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo.
CL2012002362A1 (es) Sales cristalinas de trometamina y de colina de un compuesto derivado de 2-tiazolil-4-quinolinil-oxi; composicion farmaceutica que las comprende, utiles para el tratamiento de la infeccion por el virus de la hepatitis c.
CL2011002386S1 (es) Motocicleta constituida por una carcasa frontal, una intermedia y una posterior, la carcasa frontal es convexa mientras que por los costados la carcasa frontal presenta dos zonas laterales rebajadas las cuales presentan un foco lateral de forma romboidal alargada.
CL2007001004A1 (es) Compuestos derivados peptidicos, inhibidores de proteasa, utiles para el tratamiento de una infeccion por el virus de la hepatitis c.
JP2013541099A5 (es)
BR112015004074A2 (pt) método para controlar pragas, uso e semente de uma planta cultivada.
NO20080158L (no) Oyedraper som inneholder roflumilast
BRPI1014691A2 (pt) Composto, e, processo para a preparação de um composto.
BRPI0814576A2 (pt) Item de calçado, e, métodos para preparar um item de calçado, e para aperfeiçoar o conforto de um item de calçado para o usuário.
CO6751279A2 (es) Composición pesticida que comprende azufre, un acaricida y un excipiente agroquímico
CL2014000451A1 (es) Metodo para sedar, anestesiar o someter a eutanasia un organismo acuático que comprende poner en contacto dicho organismo con linalol; composición que comprende linalol y al menos un solvente o surfactante.
WO2012078051A3 (en) IPN Vaccine
AR075301A1 (es) Composicion y metodo para controlar enfermedades de plantas